In a novel proof of concept study, published on the bioRxiv* preprint server, U.S. researchers used attenuated influenza viral particles that express severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain to induce neutralizing antibodies in mice – unveiling another viable vaccine candidate for preventing coronavirus disease (COVID-19). Colorized scanning electron micrograph of an apoptotic
0 Comments
On August 13, a Reuters exclusive revealed how the US is recruiting scientists from both South Africa and Latin America to test vaccine candidates in US-backed trials while also promising to ease these nation’s access to a successful vaccine. Moncef Slaoui, the former pharma executive who leads Warp Speed, “made the commitment to international scientists late last
0 Comments
Vietnam has registered to buy a Russian COVID-19 vaccine, state television reported on Friday, as it fights a new outbreak after going several months with no local cases. Russia said on Wednesday that it would roll out the world’s first COVID-19 vaccine within two weeks, rejecting the concerns of experts who said it should not
0 Comments
http://armandoh.org/ https://www.facebook.com/ArmandoHasudungan Support me: http://www.patreon.com/armando Instagram: http://instagram.com/armandohasudungan Twitter: https://twitter.com/Armando71021105
0 Comments
Ranked as the 18th largest healthcare system in the United States, Kaiser Permanente isn’t afraid of ambitious targets as its’ California-based research organizations are no exception, raising the bar by planning to enroll up to 5% of all study participants in the worldwide Phase 3 Pfizer and BioNTech BNT162b2 clinical trial. Kaiser Permanente commenced participation in the
0 Comments
The initial reporter provides a narrative describing the event in the report submitted to FDA. The narrative is not included in the FAERS (formerly AERS) quarterly data files or FAERS Public Dashboard. Related Links: Purpose We hypothesized that IBU would exacerbate intestinal injury, reduce exercise performance, and increase susceptibility to heat stroke. Methods To test
0 Comments
Summary Company Announcement Date: August 12, 2020 FDA Publish Date: August 12, 2020 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential for Salmonella Company Name: Kroger Delta Division Brand Name: Brand Name(s) MURRAY’S, JARLSBERG, DELI Product Description: Product Description Cheese Dip Company Announcement Kroger Delta Division is recalling cheese dips sold
0 Comments
Beginning early on in the coronavirus pandemic, some researchers looked to experiences of past outbreaks for lessons, proposing that some patients might be saved by a decidedly old-fashioned remedy: plasma taken from people who’d recovered from the disease in infused into patients. The idea is that such plasma contains antibodies against SARS-CoV-2 that can give
0 Comments
Sinopharm’s COVID-19 vaccine candidate has triggered antibody responses in early-stage trials. Almost all participants in the phase 1 and 2 trials who received the vaccine had an antibody response. The phase 1 trial tested three different doses in 96 participants, while the phase 2 study tested a medium dose in 224 participants. Sinopharm’s COVID-19 vaccine
0 Comments
Neuroendocrine tumors (NETs) are a group of rare, heterogeneous tumors that can develop sporadically in many different organs of the body. They arise from specialized cells of the nervous and endocrine system called the neuroendocrine cells. The majority of NETs occur in the gastrointestinal tract followed by the lungs, pancreas, and thymus. In about 15%
0 Comments
Reviewed by Emily Henderson, B.Sc.Aug 14 2020 A new Boston University School of Public Health (BUSPH) study finds that changes in weight between young adulthood and midlife may have important consequences for a person’s risk of early death. Published in JAMA Network Open, the study found that participants whose BMIs went from the “obese” range
0 Comments
Led by Associate Professor Andrew Mallett, University of Queensland researchers secured $2.57 million in federal funding in Australia recently to conduct a clinical trial on the effectiveness of the low-cost diabetes medication, metformin, and its role in autosomal dominant polycystic kidney disease (ADPKD). Historically, there has been a lack of funding and awareness associated with
0 Comments
August 14th, 2020 Medgadget Editors Diagnostics, Emergency Medicine, Medicine, Orthopedic Surgery, Radiology, Sports Medicine Canon Medical is releasing a compact new mobile digital X-ray. The SOLTUS 500, powered by a 40kW generator, has touch screens both at the main unit and at the collimator, making it easier and quicker to operate it around patients. Detectors
0 Comments
“Never let a good crisis go to waste. It’s the universe challenging you to learn something new and rise to the next level of your potential.”  – Kristen Ulmer I’ve always been an optimist. And for the most part, I’ve remained positive during the pandemic. Not that my head has been stuck in the Pollyanna
0 Comments
Source: Kaiser Ahmad Dar, used with permission COVID-19 is impacting countries worldwide in manifold ways. In India, the coronavirus situation has grown worse with the country becoming one of the top five highest affected. However, culture and tradition—among other things—have shaped how both the government and general public in India have become more resilient. Kaiser Ahmad
0 Comments
Listening to experts about what you should eat can be dizzying. For instance, some swear by a plant-based high fiber diet while others recommend that a meat-based diet is the way to go. Then there are those who promise longevity with a reduced intake of saturated fatty acids such as the  Mediterranean diet, while others
0 Comments
With the World Health Organization this week publishing a list of the latest Covid-19 candidate vaccines from around the world, Pharma IQ’s weekly round-up looks at developments from the past seven days including news on how the pharma industry plans to handle vaccine disruption and flu season. New pharma partnership prepares air cargo industry for
0 Comments
Sickle cell disease (SCD) is a genetic blood disorder that alters red blood cells. Credit: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. Sign up here for GlobalData’s free bi-weekly Covid-19 report on the latest information your industry needs to know. Biopharmaceutical firm Imara has started dosing patients in the Phase IIb
0 Comments
The International Narcotics Control Board (INCB), the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) call on governments to ensure that the procurement and supply of controlled medicines in countries meet the needs of patients, both those who have COVID-19 and those who require internationally controlled medicines for other
0 Comments
UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing of the COVID-19 vaccine candidate known as BTN162, developed by Germany’s BioNTech and Pfizer Inc. The addition of this pivotal clinical trial adds even a more significant component to the university’s response to COVID-19. Now Davis,
0 Comments
TURN OFF YOUR TV! Source: Wikimedia Commons; derivative work: Abanima I’m sick of all the false stories, lies, half-truths, omitted evidence… in short: propaganda that attempts to alter my beliefs every day in the media. Little things like… Covid19 Orwellian newspeak: Social Distancing (which is actually anti-social physical distancing), New Normal (which is as far
0 Comments
Source: Katie Willard Virant As someone who has lived with chronic illness since my youth, I spent many years believing I would be unable ever to travel.  With fatigue and pain as constant companions and the ever-present threat of flare-ups requiring immediate surgery and/or hospitalization, it seemed a wiser course to stay close to home. 
0 Comments
Today’s guest post comes from Julia Phillips, VP of Pharma Accounts and Enablement at CoverMyMeds. Julia discusses the challenges of both access to therapy and patient adherence, specifically during the COVID-19 pandemic. CoverMyMeds’ technology solutions mitigate these issues and ultimately improve patient outcomes. To learn more, download the CoverMyMeds case study, Overcoming Medication Access Barriers
0 Comments